Creating entrance in new markets, building strong indepth KOL relationships, cross functional leading skills. Startup of Investigational Initiated Trials (IIT’s or IST's) Broad network in Dutch and Belgium Medical Immuno-Oncology Field. For the Netherlands also in the field of Haematology, coop-group (HOVON) and their chair members. Specialties: Initiate and conduct new treatments in close cooperation with leading specialists in immuno-oncology/hematology departments. Innovator, team player and positive hands-on mentality.
Medical Science Liaison
Since July 2016
MSL work in Ovarian Cancer (OC) and Soft Tissue Sarcoma (STS). KOL engagement and trial management. With marketed products and pipeline.
Market Access Manager BNLX
Since December 2015
Business Consultant / Executive Partner
Since September 2013
BioteqPartner BV is a specialised consultancy firm in Medical Affairs, Strategic Market Access and Commercial Deployment in the pharmaceutical field and medical devices for the BeNeLux markets.
Consultancy services for US based Immuno-Oncology start ups
September 2015 --- December 2015
Explore the strategic imperatives to make the step overseas.
Medical Science Lead Belgium & Netherlands
October 2013 --- July 2015
Business Manager - Benelux
January 2012 --- September 2013
Starting up the BeNeLux franchise. Filing for reimbursement, KOL development, disease awareness, Ad Boards, Named Patient Program, Risk Sharing Program w Health Care providers, Guideline support.
Business Manager - Netherlands
April 2011 --- December 2011
National Reimbursement of the product Paradigm shift in disease Management KOL Development Expert Input Meeting Make product available for Hospitals Implementation of Distribution through Whole Salers Marketing Medical Messaging WINNING the DUTCH GALENUS Price for most innovative new drug (may 2012)
Medical Officer Oncology
February 2010 --- March 2011
Day to day business of the Medical Department Oncology. Medical Plan, Long Term Medical Strategic Planning, Develop Medical Messaging, Ensure medical correctness in all medical, marketing, and sales materials, Building Medical Team, Discuss, Design, Start, Fund, Closing of IST's (IIT's), Publication activities at the local level, Training of the Sales Force, 1-5Year Financial Budget Planning of the Medical Oncology department. Product forecast and supply, KOL management, International KOL Meetings during congresses. Having Fun. Organization of and participation in medical and marketing activities at local and HQ level, such as advisory boards, workshops, press releases and creation of material for distribution by sales representatives. Medical review of local regulatory and reimbursement dossiers
Medical Specialist Oncology
December 2005 --- October 2009
Internal function name Medical Liason. In other farmaceutical company's also know as Medical Advisor. Focus in contacts on the Key Opinion Leaders in the Netherlands in the field of expertise Hematology (NHL, MDS, Oral Mucositis and ITP) and Oncology (Breast Ca, Colon Ca, Lung Ca). Primary contact coop-groups are HOVON, NVALT and BOOG and their members.
Sr BioPharmaceutical Specialist
November 2004 --- November 2005
Sales Representative (Marketing and Sales) in the field of Oncology and Hematology. Promotion of the products Aranesp, Neulasta and Neupogen. Introduction of the concept 2care in the region Mid East Netherlands.
Account Manager Nephrology
July 2001 --- October 2004
Winner of Amgen Chairman's circle 2002. Pre-markted and marketed introduction of the long acting epoetin Aranesp in the dutch Dialysis market (june 2001). Aranesp was these days mainly an intramural hospital product. Selling the product was a DMU based decision (ie Pharmacist, Hospital Purchaser and the Nephrology ward (Nephrologists and head Dialysis). Contract size between 3K€ and 2M€/year. Large Account Management skills developed.
Clinical Trial Monitor
July 2000 --- June 2001
Monitoring phase III study of the product Darbepoetin-alfa (Aranesp)in the Nephrology/Dialysis setting (CRA like).
Product Manager Immunoglobulines
January 1999 --- June 2000
Productmanager at the Dutch not for profit organization CLB Amsterdam(Central Laboratory for Bloodtransfusions) currently know as Sanquin. Marketed products: Immunoglobuline IV (IVIG) a CLB manufactured specialité and the post-introduction of Ivegam(r) a liquid IVIG. Develop a program for out of hospital admission of IVIG. Develop detail-aid, Develop product visual, Write Medical input for Quartly Newsletter on disease topics, Producttraining of the field force. Key contact for Dutch KOL's.
March 1996 --- December 1998
Rayon manager GP’s and Specialists
January 1995 --- January 1996
MSc in Biomedical Sciences from VU University Amsterdam in 1994
Postdoc in Management from VU University Amsterdam in 1994
Propaedeuse in Chemistry from VU University Amsterdam in 1990
in from Pieter Nieuwland College Amsterdam in 1988
in from De Kring in 1981